132 related articles for article (PubMed ID: 12761250)
1. Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria.
Shimizu H; Maruyama S; Yuzawa Y; Kato T; Miki Y; Suzuki S; Sato W; Morita Y; Maruyama H; Egashira K; Matsuo S
J Am Soc Nephrol; 2003 Jun; 14(6):1496-505. PubMed ID: 12761250
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury.
Furuichi K; Wada T; Iwata Y; Kitagawa K; Kobayashi K; Hashimoto H; Ishiwata Y; Tomosugi N; Mukaida N; Matsushima K; Egashira K; Yokoyama H
J Am Soc Nephrol; 2003 Apr; 14(4):1066-71. PubMed ID: 12660342
[TBL] [Abstract][Full Text] [Related]
3. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation.
Tatewaki H; Egashira K; Kimura S; Nishida T; Morita S; Tominaga R
J Vasc Surg; 2007 Jun; 45(6):1236-43. PubMed ID: 17543688
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis.
Wada T; Furuichi K; Sakai N; Iwata Y; Kitagawa K; Ishida Y; Kondo T; Hashimoto H; Ishiwata Y; Mukaida N; Tomosugi N; Matsushima K; Egashira K; Yokoyama H
J Am Soc Nephrol; 2004 Apr; 15(4):940-8. PubMed ID: 15034096
[TBL] [Abstract][Full Text] [Related]
5. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria.
Eddy AA; Giachelli CM
Kidney Int; 1995 Jun; 47(6):1546-57. PubMed ID: 7643523
[TBL] [Abstract][Full Text] [Related]
6. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats.
Ikeda Y; Yonemitsu Y; Kataoka C; Kitamoto S; Yamaoka T; Nishida K; Takeshita A; Egashira K; Sueishi K
Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H2021-8. PubMed ID: 12384481
[TBL] [Abstract][Full Text] [Related]
7. Involvement of MCP-1 in tubulointerstitial fibrosis through massive proteinuria in anti-GBM nephritis induced in WKY rats.
Taniguchi H; Kojima R; Sade H; Furuya M; Inomata N; Ito M
J Clin Immunol; 2007 Jul; 27(4):409-29. PubMed ID: 17516154
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory gene therapy for cardiovascular disease.
Matoba T; Egashira K
Curr Gene Ther; 2011 Dec; 11(6):442-6. PubMed ID: 22023473
[TBL] [Abstract][Full Text] [Related]
9. Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats.
Tsuruta S; Nakamuta M; Enjoji M; Kotoh K; Hiasa K; Egashira K; Nawata H
Int J Mol Med; 2004 Nov; 14(5):837-42. PubMed ID: 15492853
[TBL] [Abstract][Full Text] [Related]
10. Exosomal CCL2 from Tubular Epithelial Cells Is Critical for Albumin-Induced Tubulointerstitial Inflammation.
Lv LL; Feng Y; Wen Y; Wu WJ; Ni HF; Li ZL; Zhou LT; Wang B; Zhang JD; Crowley SD; Liu BC
J Am Soc Nephrol; 2018 Mar; 29(3):919-935. PubMed ID: 29295871
[TBL] [Abstract][Full Text] [Related]
11. Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeys.
Nakano K; Egashira K; Ohtani K; Zhao G; Funakoshi K; Ihara Y; Sunagawa K
Atherosclerosis; 2007 Oct; 194(2):309-16. PubMed ID: 17126840
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.
Gong R; Rifai A; Tolbert EM; Biswas P; Centracchio JN; Dworkin LD
J Am Soc Nephrol; 2004 Nov; 15(11):2868-81. PubMed ID: 15504940
[TBL] [Abstract][Full Text] [Related]
13. Transfection with a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene improves cardiac function after 6 hours of cold preservation.
Kajihara N; Morita S; Nishida T; Tatewaki H; Eto M; Egashira K; Yasui H
Circulation; 2003 Sep; 108 Suppl 1():II213-8. PubMed ID: 12970235
[TBL] [Abstract][Full Text] [Related]
14. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice.
Shimizu S; Nakashima H; Masutani K; Inoue Y; Miyake K; Akahoshi M; Tanaka Y; Egashira K; Hirakata H; Otsuka T; Harada M
Rheumatology (Oxford); 2004 Sep; 43(9):1121-8. PubMed ID: 15213333
[TBL] [Abstract][Full Text] [Related]
15. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
[TBL] [Abstract][Full Text] [Related]
16. Anti-monocyte chemoattractant protein-1 gene therapy protects against focal brain ischemia in hypertensive rats.
Kumai Y; Ooboshi H; Takada J; Kamouchi M; Kitazono T; Egashira K; Ibayashi S; Iida M
J Cereb Blood Flow Metab; 2004 Dec; 24(12):1359-68. PubMed ID: 15625410
[TBL] [Abstract][Full Text] [Related]
17. Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels.
Zhong L; Chen WQ; Ji XP; Zhang M; Zhao YX; Yao GH; Zhang PF; Zhang C; Zhang Y
J Cell Mol Med; 2008 Dec; 12(6A):2362-71. PubMed ID: 18266972
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of monocyte chemoattractant protein-1 expression in tubular epithelium attenuates tubulointerstitial alteration in rat Goodpasture syndrome.
Okada H; Moriwaki K; Kalluri R; Imai H; Ban S; Takahama M; Suzuki H
Kidney Int; 2000 Mar; 57(3):927-36. PubMed ID: 10720946
[TBL] [Abstract][Full Text] [Related]
19. Mutant monocyte chemoattractant protein 1 protein attenuates migration of and inflammatory cytokine release by macrophages exposed to orthopedic implant wear particles.
Yao Z; Keeney M; Lin TH; Pajarinen J; Barcay K; Waters H; Egashira K; Yang F; Goodman S
J Biomed Mater Res A; 2014 Sep; 102(9):3291-7. PubMed ID: 24123855
[TBL] [Abstract][Full Text] [Related]
20. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys.
Egashira K; Nakano K; Ohtani K; Funakoshi K; Zhao G; Ihara Y; Koga J; Kimura S; Tominaga R; Sunagawa K
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2563-8. PubMed ID: 17885211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
